Novel interactions of CLN5 support molecular networking between Neuronal Ceroid Lipofuscinosis proteins

BMC Cell Biology

Volumn 10, Issue , 2009, Pages

  Lyly, Annina ^a   von Schantz, Carina ^a   Heine, Claudia ^a   Schmiedt, Mia Lisa ^a   Sipilä, Tessa ^a   Jalanko, Anu ^a   Kyttälä, Aija ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CLN3 PROTEIN; CLN6 PROTEIN; CLN8 PROTEIN; GLYCOPROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; NEURONAL CEROID LIPOFUSCINOSIS PROTEIN; PALMITOYL PROTEIN THIOSTERASE 1; PROTEIN CLN5; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TRIPEPTIDYL PEPTIDASE I; UNCLASSIFIED DRUG; CLN5 PROTEIN, HUMAN; CLN5 PROTEIN, MOUSE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL CELL; ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME BINDING; GENE MUTATION; GENE OVEREXPRESSION; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LYSOSOME; NEURONAL CEROID LIPOFUSCINOSIS; NONHUMAN; PATHOGENESIS; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CELL LINE; CERCOPITHECUS; GENETICS; METABOLISM; MOUSE; MOUSE MUTANT; PROTEIN BINDING; PROTEIN TRANSPORT;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; ENDOPLASMIC RETICULUM; GOLGI APPARATUS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONAL CEROID-LIPOFUSCINOSES; PROTEIN BINDING; PROTEIN TRANSPORT; PROTON-TRANSLOCATING ATPASES;

EID: 71949103162     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-10-83     Document Type: Article

References (52)

1. Haltia M. The neuronal ceroid-lipofuscinoses: from past to present. Biochim Biophys Acta 2006, 1762(10):850-856.
2. Santavuori P. Neuronal ceroid-lipofuscinoses in childhood. Brain Dev 1988, 10(2):80-83.
3. Siintola E, Lehesjoki AE, Mole SE. Molecular genetics of the NCLs -- status and perspectives. Biochim Biophys Acta 2006, 1762(10):857-864.
4. Siintola E, Topcu M, Aula N, Lohi H, Minassian BA, Paterson AD, Liu XQ, Wilson C, Lahtinen U, Anttonen AK. The Novel Neuronal Ceroid Lipofuscinosis Gene MFSD8 Encodes a Putative Lysosomal Transporter. Am J Hum Genet 2007, 81(1):136-146. 10.1086/518902, 1950917, 17564970.
5. Siintola E, Partanen S, Stromme P, Haapanen A, Haltia M, Maehlen J, Lehesjoki AE, Tyynela J. Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain 2006, 129(Pt 6):1438-1445. 10.1093/brain/awl107, 16670177.
6. Palmer DN, Fearnley IM, Walker JE, Hall NA, Lake BD, Wolfe LS, Haltia M, Martinus RD, Jolly RD. Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease). Am J Med Genet 1992, 42(4):561-567. 10.1002/ajmg.1320420428, 1535179.
7. Tyynela J, Palmer DN, Baumann M, Haltia M. Storage of saposins A and D in infantile neuronal ceroid-lipofuscinosis. FEBS Lett 1993, 330(1):8-12. 10.1016/0014-5793(93)80908-D, 8370464.
8. Cooper JD, Russell C, Mitchison HM. Progress towards understanding disease mechanisms in small vertebrate models of neuronal ceroid lipofuscinosis. Biochim Biophys Acta 2006, 1762(10):873-889.
9. Hellsten E, Vesa J, Olkkonen VM, Jalanko A, Peltonen L. Human palmitoyl protein thioesterase: evidence for lysosomal targeting of the enzyme and disturbed cellular routing in infantile neuronal ceroid lipofuscinosis. Embo J 1996, 15(19):5240-5245. 452268, 8895569.
10. Sleat DE, Donnelly RJ, Lackland H, Liu CG, Sohar I, Pullarkat RK, Lobel P. Association of mutations in a lysosomal protein with classical late- infantile neuronal ceroid lipofuscinosis. Science 1997, 277(5333):1802-1805. 10.1126/science.277.5333.1802, 9295267.
11. Tang J, Wong RN. Evolution in the structure and function of aspartic proteases. Journal of cellular biochemistry 1987, 33(1):53-63. 10.1002/jcb.240330106, 3546346.
12. Jarvela I, Sainio M, Rantamaki T, Olkkonen V, Carpen O, Peltonen L, Jalanko A. Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease. Hum Mol Genet 1998, 7(1):85-90. 10.1093/hmg/7.1.85, 9384607.
13. Lonka L, Kyttala A, Ranta S, Jalanko A, Lehesjoki AE. The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum. Hum Mol Genet 2000, 9(11):1691-1697. 10.1093/hmg/9.11.1691, 10861296.
14. Mole SE, Michaux G, Codlin S, Wheeler RB, Sharp JD, Cutler DF. CLN6, which is associated with a lysosomal storage disease, is an endoplasmic reticulum protein. Exp Cell Res 2004, 298(2):399-406. 10.1016/j.yexcr.2004.04.042, 15265688.
15. Kyttala A, Lahtinen U, Braulke T, Hofmann SL. Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteins. Biochim Biophys Acta 2006, 1762(10):920-933.
16. Holmberg V, Jalanko A, Isosomppi J, Fabritius AL, Peltonen L, Kopra O. The mouse ortholog of the neuronal ceroid lipofuscinosis CLN5 gene encodes a soluble lysosomal glycoprotein expressed in the developing brain. Neurobiol Dis 2004, 16(1):29-40. 10.1016/j.nbd.2003.12.019, 15207259.
17. Savukoski M, Klockars T, Holmberg V, Santavuori P, Lander ES, Peltonen L. CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. Nat Genet 1998, 19(3):286-288. 10.1038/975, 9662406.
18. Isosomppi J, Vesa J, Jalanko A, Peltonen L. Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein. Hum Mol Genet 2002, 11(8):885-891. 10.1093/hmg/11.8.885, 11971870.
19. Ahtiainen L, Van Diggelen OP, Jalanko A, Kopra O. Palmitoyl protein thioesterase 1 is targeted to the axons in neurons. J Comp Neurol 2003, 455(3):368-377. 10.1002/cne.10492, 12483688.
20. Lehtovirta M, Kyttala A, Eskelinen EL, Hess M, Heinonen O, Jalanko A. Palmitoyl protein thioesterase (PPT) localizes into synaptosomes and synaptic vesicles in neurons: implications for infantile neuronal ceroid lipofuscinosis (INCL). Hum Mol Genet 2001, 10(1):69-75. 10.1093/hmg/10.1.69, 11136716.
21. Luiro K, Kopra O, Lehtovirta M, Jalanko A. CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease. Hum Mol Genet 2001, 10(19):2123-2131. 10.1093/hmg/10.19.2123, 11590129.
22. Bessa C, Teixeira CA, Mangas M, Dias A, Sa Miranda MC, Guimaraes A, Ferreira JC, Canas N, Cabral P, Ribeiro MG. Two novel CLN5 mutations in a Portuguese patient with vLINCL: insights into molecular mechanisms of CLN5 deficiency. Mol Genet Metab 2006, 89(3):245-253. 10.1016/j.ymgme.2006.04.010, 16814585.
23. Vesa J, Chin MH, Oelgeschlager K, Isosomppi J, DellAngelica EC, Jalanko A, Peltonen L. Neuronal Ceroid Lipofuscinoses Are Connected at Molecular Level: Interaction of CLN5 Protein with CLN2 and CLN3. Mol Biol Cell 2002, 13(7):2410-2420. 10.1091/mbc.E02-01-0031, 117323, 12134079.
24. Sleat DE, Lackland H, Wang Y, Sohar I, Xiao G, Li H, Lobel P. The human brain mannose 6-phosphate glycoproteome: a complex mixture composed of multiple isoforms of many soluble lysosomal proteins. Proteomics 2005, 5(6):1520-1532. 10.1002/pmic.200401054, 15789345.
25. Kollmann K, Mutenda KE, Balleininger M, Eckermann E, von Figura K, Schmidt B, Lubke T. Identification of novel lysosomal matrix proteins by proteome analysis. Proteomics 2005, 5(15):3966-3978. 10.1002/pmic.200401247, 16145712.
26. Lyly A, von Schantz C, Salonen T, Kopra O, Saarela J, Jauhiainen M, Kyttala A, Jalanko A. Glycosylation, transport, and complex formation of palmitoyl protein thioesterase 1 (PPT1) - distinct characteristics in neurons. BMC Cell Biol 2007, 8(1):22. 10.1186/1471-2121-8-22, 1906764, 17565660.
27. Kida E, Golabek AA, Walus M, Wujek P, Kaczmarski W, Wisniewski KE. Distribution of tripeptidyl peptidase I in human tissues under normal and pathological conditions. Journal of neuropathology and experimental neurology 2001, 60(3):280-292.
28. Jalanko A, Vesa J, Manninen T, von Schantz C, Minye H, Fabritius AL, Salonen T, Rapola J, Gentile M, Kopra O. Mice with Ppt1(Deltaex4) mutation replicate the INCL phenotype and show an inflammation-associated loss of interneurons. Neurobiol Dis 2005, 18(1):226-241. 10.1016/j.nbd.2004.08.013, 15649713.
29. Kopra O, Vesa J, von Schantz C, Manninen T, Minye H, Fabritius AL, Rapola J, van Diggelen OP, Saarela J, Jalanko A. A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging. Hum Mol Genet 2004, 13(23):2893-2906. 10.1093/hmg/ddh312, 15459177.
30. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif) 2001, 25(4):402-408.
31. Lyly A, Marjavaara SK, Kyttala A, Uusi-Rauva K, Luiro K, Kopra O, Martinez LO, Tanhuanpaa K, Kalkkinen N, Suomalainen A. Deficiency of the INCL protein Ppt1 results in changes in ectopic F1-ATP synthase and altered cholesterol metabolism. Hum Mol Genet 2008, 17(10):1406-1417. 10.1093/hmg/ddn028, 18245779.
32. Johansson M, Lehto M, Tanhuanpaa K, Cover TL, Olkkonen VM. The oxysterol-binding protein homologue ORP1L interacts with Rab7 and alters functional properties of late endocytic compartments. Molecular biology of the cell 2005, 16(12):5480-5492. 10.1091/mbc.E05-03-0189, 1289395, 16176980.
33. Golabek AA, Kida E, Walus M, Wujek P, Mehta P, Wisniewski KE. Biosynthesis, glycosylation, and enzymatic processing in vivo of human tripeptidyl-peptidase I. J Biol Chem 2003, 278(9):7135-7145. 10.1074/jbc.M211872200, 12488460.
34. Vesa J, Hellsten E, Verkruyse LA, Camp LA, Rapola J, Santavuori P, Hofmann SL, Peltonen L. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 1995, 376(6541):584-587. 10.1038/376584a0, 7637805.
35. van Diggelen OP, Thobois S, Tilikete C, Zabot MT, Keulemans JL, van Bunderen PA, Taschner PE, Losekoot M, Voznyi YV. Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: first adult-onset patients of a childhood disease. Ann Neurol 2001, 50(2):269-272. 10.1002/ana.1103, 11506414.
36. Sleat DE, Sohar I, Pullarkat PS, Lobel P, Pullarkat RK. Specific alterations in levels of mannose 6-phosphorylated glycoproteins in different neuronal ceroid lipofuscinoses. Biochem J 1998, 334(Pt 3):547-551. 1219721, 9729460.
37. Junaid MA, Pullarkat RK. Increased brain lysosomal pepstatin-insensitive proteinase activity in patients with neurodegenerative diseases. Neurosci Lett 1999, 264(1-3):157-160. 10.1016/S0304-3940(99)00095-6, 10320038.
38. Tammen I, Houweling PJ, Frugier T, Mitchell NL, Kay GW, Cavanagh JA, Cook RW, Raadsma HW, Palmer DN. A missense mutation (c.184C>T) in ovine CLN6 causes neuronal ceroid lipofuscinosis in Merino sheep whereas affected South Hampshire sheep have reduced levels of CLN6 mRNA. Biochim Biophys Acta 2006, 1762(10):898-905.
39. Persaud-Sawin DA, Mousallem T, Wang C, Zucker A, Kominami E, Boustany RM. Neuronal ceroid lipofuscinosis: a common pathway?. Pediatr Res 2007, 61(2):146-152. 10.1203/pdr.0b013e31802d8a4a, 17237713.
40. Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium. Cell 1995, 82(6):949-957. 10.1016/0092-8674(95)90274-0, 7553855.
41. Kitzmuller C, Haines RL, Codlin S, Cutler DF, Mole SE. A function retained by the common mutant CLN3 protein is responsible for the late onset of juvenile neuronal ceroid lipofuscinosis. Hum Mol Genet 2008, 17(2):303-312. 10.1093/hmg/ddm306, 17947292.
42. Lange PF, Wartosch L, Jentsch TJ, Fuhrmann JC. ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function. Nature 2006, 440(7081):220-223. 10.1038/nature04535, 16525474.
43. Reczek D, Schwake M, Schroder J, Hughes H, Blanz J, Jin X, Brondyk W, Van Patten S, Edmunds T, Saftig P. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase. Cell 2007, 131(4):770-783. 10.1016/j.cell.2007.10.018, 18022370.
44. Isosomppi J, Heinonen O, Hiltunen JO, Greene ND, Vesa J, Uusitalo A, Mitchison HM, Saarma M, Jalanko A, Peltonen L. Developmental expression of palmitoyl protein thioesterase in normal mice. Brain Res Dev Brain Res 1999, 118(1-2):1-11. 10.1016/S0165-3806(99)00115-7, 10611498.
45. Heinonen O, Salonen T, Jalanko A, Peltonen L, Copp A. CLN-1 and CLN-5, genes for infantile and variant late infantile neuronal ceroid lipofuscinoses, are expressed in the embryonic human brain. J Comp Neurol 2000, 426(3):406-412. 10.1002/1096-9861(20001023)426:3<406::AID-CNE5>3.0.CO;2-5, 10992246.
46. von Schantz C, Saharinen J, Kopra O, Cooper JD, Gentile M, Hovatta I, Peltonen L, Jalanko A. Brain gene expression profiles of Cln1 and Cln5 deficient mice unravels common molecular pathways underlying neuronal degeneration in NCL diseases. BMC Genomics 2008, 9:146. 10.1186/1471-2164-9-146, 2323392, 18371231.
47. Martinez LO, Jacquet S, Esteve JP, Rolland C, Cabezon E, Champagne E, Pineau T, Georgeaud V, Walker JE, Terce F. Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis. Nature 2003, 421(6918):75-79. 10.1038/nature01250, 12511957.
48. Ahtiainen L, Kolikova J, Mutka AL, Luiro K, Gentile M, Ikonen E, Khiroug L, Jalanko A, Kopra O. Palmitoyl protein thioesterase 1 (Ppt1)-deficient mouse neurons show alterations in cholesterol metabolism and calcium homeostasis prior to synaptic dysfunction. Neurobiol Dis 2007, 28(1):52-64. 10.1016/j.nbd.2007.06.012, 17656100.
49. Haidar B, Kiss RS, Sarov-Blat L, Brunet R, Harder C, McPherson R, Marcel YL. Cathepsin D, a Lysosomal Protease, Regulates ABCA1-mediated Lipid Efflux. J Biol Chem 2006, 281(52):39971-39981. 10.1074/jbc.M605095200, 17032648.
50. Jalanko A, Tyynela J, Peltonen L. From genes to systems: new global strategies for the characterization of NCL biology. Biochim Biophys Acta 2006, 1762(10):934-944.
51. Narayan SB, Rakheja D, Tan L, Pastor JV, Bennett MJ. CLN3P, the Batten's disease protein, is a novel palmitoyl-protein Delta-9 desaturase. Ann Neurol 2006, 60(5):570-577. 10.1002/ana.20975, 17036287.
52. Winter E, Ponting CP. TRAM, LAG1 and CLN8: members of a novel family of lipid-sensing domains?. Trends in biochemical sciences 2002, 27(8):381-383. 10.1016/S0968-0004(02)02154-0, 12151215.